121 related articles for article (PubMed ID: 19900523)
1. Understanding polymer-lipid solid dispersions--the properties of incorporated lipids govern the crystallisation behaviour of PEG.
Unga J; Matsson P; Mahlin D
Int J Pharm; 2010 Feb; 386(1-2):61-70. PubMed ID: 19900523
[TBL] [Abstract][Full Text] [Related]
2. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
[TBL] [Abstract][Full Text] [Related]
3. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
[TBL] [Abstract][Full Text] [Related]
4. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000.
Cwiertnia B
Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877
[TBL] [Abstract][Full Text] [Related]
5. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
7. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
Wang X; Michoel A; Van den Mooter G
Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
[TBL] [Abstract][Full Text] [Related]
8. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the microstructure of semicrystalline solid dispersions.
Zhu Q; Taylor LS; Harris MT
Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
[TBL] [Abstract][Full Text] [Related]
11. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nonionic PEO-PPO diblock copolymers with lipid bilayers.
Firestone MA; Seifert S
Biomacromolecules; 2005; 6(5):2678-87. PubMed ID: 16153106
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
Campbell K; Craig DQ; McNally T
Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
[TBL] [Abstract][Full Text] [Related]
15. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.
Janssens S; Denivelle S; Rombaut P; Van den Mooter G
Eur J Pharm Sci; 2008 Oct; 35(3):203-10. PubMed ID: 18656535
[TBL] [Abstract][Full Text] [Related]
16. The apparent plasticizing effect of polyethylene glycol (PEG) on the crystallinity of spray dried lactose/PEG composites.
Mosén K; Bäckström K; Thalberg K; Schaefer T; Axelsson A; Kristensen HG
Eur J Pharm Biopharm; 2006 Oct; 64(2):206-11. PubMed ID: 16846723
[TBL] [Abstract][Full Text] [Related]
17. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers.
Chen Z; Liu Z; Qian F
Mol Pharm; 2015 Feb; 12(2):590-9. PubMed ID: 25569586
[TBL] [Abstract][Full Text] [Related]
18. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
19. The thermotropic phase behaviour and phase structure of a homologous series of racemic beta-D-galactosyl dialkylglycerols studied by differential scanning calorimetry and X-ray diffraction.
Mannock DA; Collins MD; Kreichbaum M; Harper PE; Gruner SM; McElhaney RN
Chem Phys Lipids; 2007 Jul; 148(1):26-50. PubMed ID: 17524381
[TBL] [Abstract][Full Text] [Related]
20. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
